Drug treatment options for HIV

July 1998
JAMA: Journal of the American Medical Association;7/1/98, Vol. 280 Issue 1, p106
Academic Journal
Describes the growing number of treatment options for HIV. Number of antiretroviral drugs know available; Concerns that HIV patients should discuss with their doctors; The need of adherence to avoid drug resistance.


Related Articles

  • Control of the medical treatment of AIDS. Velichenko, V.; Pritykin, D. // Automation & Remote Control;Mar2006, Vol. 67 Issue 3, p493 

    This work deals with the statement and the solution of problems of optimal control of the human immune system affected by a human immunodeficiency virus (HIV). The solution is performed by the numerical methods of optimal control on the basis of a dynamic model of the development of an infection...

  • Immune control of HIV-1 after early treatment of acute infection. Rosenberg, Eric S.; Altfeld, Marcus; Poon, Samuel H.; Phillips, Mary N.; Wilkes, Barbara M.; Eldridge, Robert L.; Robbins, Gregory K.; D'Aquila, Richard T.; Goulder, Philip J.R.; Walker, Bruce D. // Nature;9/28/2000, Vol. 407 Issue 6803, p523 

    Presents a study in which treatment interruptions were administered to eight HIV-positive subjects with treated acute infection, with the plan to restart therapy if the viral load exceeded a certain level. Viral load below 5,000 RNA copies per milliliter which was acheived by all subjects;...

  • Reversal of Human Immunodeficiency Virus Type 1-Associated Hematosuppression by Effective Antiretroviral Therapy. Huang, Susan S.; Barbour, Jason D.; Deeks, Steven G.; Huang, Jeannie S.; Grant, Robert M.; Ng, Valerie L.; McCune, Joseph M. // Clinical Infectious Diseases;3/1/2000, Vol. 30 Issue 3, p504 

    Examines the reversal of HIV type 1-associated hematosuppression by effective antiretroviral therapy. Effects of durable viral suppression on multilineage hematopoiesis in 66 HIV-1 seropositive patients; Increase in circulating CD4(sup +) T cell counts and circulating levels of other...

  • HIV testing in primary care. Bryce, Gavin // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/25/2009, Vol. 338 Issue 7701, p966 

    The author reflects on the benefits of early HIV testing in primary care in Great Britain. He suggests that pilot programs in the country which focus on early diagnosis can be a powerful prevention tool at an individual and community level. He argues that early diagnosis and treatment is cost...

  • Trial suggests vaccines could aid HIV therapy. Check, Erika // Nature;4/17/2003, Vol. 422 Issue 6933, p650 

    Reports on the therapeutic vaccine that could aid HIV therapy. Benefits of the vaccine; Features of the vaccine.

  • HIV-1, NFAT, and Cyclosporin: Immunosuppression for the Immunosuppressed? Cron, Randy Q. // DNA & Cell Biology;Dec2001, Vol. 20 Issue 12, p761 

    The human immunodeficiency virus-1 (HIV-1), the cause of AIDS, remains a significant cause of morbidity and mortality throughout the planet. Although reverse transcriptase and protease inhibitors have substantially slowed the virus, viral resistance complicates therapy. Because HIV-1 relies on...

  • GERMAN AIDS NUMBERS DROP. Wockner, Rex // Bay Windows;4/14/1999, pN.PAG 

    Presents information on the number of AIDS cases in Germany as of April 14, 1999. Decrease in the number of AIDS cases in 1998 compared in 1997; Total number of Germans that developed AIDS.

  • Targeting HIV Interventions for Adolescent Girls and Young Women in Southern Africa: Use of the PLACE Methodology in Hwange District, Zimbabwe. Singh, Kavita; Sambisa, William; Munyati, Shungu; Chandiwana, Brian; Chingono, Alfred; Monash, Roeland; Weir, Sharon // AIDS & Behavior;Feb2010, Vol. 14 Issue 1, p200 

    This paper addresses the issue of how to target interventions to girls 15–19 and young women 20–24 in a resource poor setting of Hwange District, Zimbabwe. The Priorities for Local AIDS Control efforts methodology was used to understand where these young people socialize and also...

  • Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. Antinori, Andrea; Ammassari, Adriana; Giancola, Maria Letizia; Cingolani, Antonella; Grisetti, Susanna; Murri, Rita; Alba, Lucia; Ciancio, Bruno; Soldani, Fabio; Larussa, Dora; Ippolito, Giuseppe; De Luca, Andrea // Journal of NeuroVirology;Aug2001, Vol. 7 Issue 4, p323 

    Whereas most AIDS-related neurologic disorders have reduced incidence since HAART therapy was introduced, we find that the incidence of progressive multifocal leukoencephalopathy (PML) did not significantly differ between the preHAART and the HAART period (OR 0.78; 95% CI 0.41-1.50). These...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics